Early gastric cancer detection by endoscopy in dyspepsia patients

1990 ◽  
Vol &NA; (756) ◽  
pp. 18
Author(s):  
&NA;
1981 ◽  
Vol 11 (2) ◽  
pp. 123-132 ◽  
Author(s):  
H. Aste ◽  
D. Amadori ◽  
C. Maltoni ◽  
M. Crespi ◽  
V. Pugliese ◽  
...  

PROTEOMICS ◽  
2016 ◽  
Vol 16 (22) ◽  
pp. 2921-2930 ◽  
Author(s):  
Wei Wu ◽  
Wen Wei Yong ◽  
Maxey C. M. Chung

1980 ◽  
Vol 66 (3) ◽  
pp. 349-356 ◽  
Author(s):  
Giancarlo Maltoni ◽  
Franco Pacini ◽  
Massimo Moriani ◽  
Dino Amadori ◽  
Angelo Ravaioli ◽  
...  

The results of a program of early gastric cancer detection, carried out in the Oncologic Institutes of Genoa, Forlì and Florence, are evaluated. General practitioners screened subjects, according to possible anamnestic and clinical risk indicators (age, family history, previous gastric lesions, digestive complaints, etc.). The diagnostic procedure consisted of medical examinations, endoscopy with cytology and/or directed biopsy, and possibly air contrast barium X-ray. Of 3,180 subjects examined, 224 had gastric cancers (7 %), 29 of which were early cancers, and 688 had high risk lesions; 1,478 cases of other pathology were detected. The authors stress that the proportion of early cancer is clearly higher than that found in routine diagnosis, yet still lower compared to the results of screening programs carried on the general population. Moreover, the high diagnostic sensitivity of each method in early gastric cancer detection and, on the other hand, the difficulties in the detection of high risk lesions, which require systematic multiple biopsies, are emphasized.


2018 ◽  
Vol 2018 ◽  
pp. 1-7 ◽  
Author(s):  
Hyun Seok Lee ◽  
Seong Woo Jeon ◽  
Sachiyo Nomura ◽  
Yasuyuki Seto ◽  
Yong Hwan Kwon ◽  
...  

Objective. The serum pepsinogen test has limitation in its predictive power as a noninvasive biomarker for gastric cancer screening. We aimed to investigate whether the combination of TFF3 and pepsinogen could be an effective biomarker for the detection of gastric cancer even in the early stages. Methods. In total, 281 patients with early gastric cancer (EGC), who underwent endoscopic submucosal dissection in Korea, and 708 healthy individuals from Japan were enrolled in the derivation cohort. The validation cohort included 30 Korean patients with EGC and 30 Korean healthy control blood donors. Serum TFF3 levels were examined using enzyme-linked immunosorbent assay. Results. Using a cutoff of 6.73 ng/mL in the derivation cohort, the sensitivity of the combination of tests for EGC detection was superior (87.5%) to that of TFF3 (80.4%) or pepsinogen test alone (39.5%). Similarly, in the validation cohort, the sensitivity of TFF3 plus pepsinogen was higher (90.4%) than that of TFF3 (80.0%) or pepsinogen test alone (33.3%). Conclusion. The combination of serum TFF3 and pepsinogen is a more effective noninvasive biomarker for gastric cancer detection compared with pepsinogen or TFF3 alone, even in EGC. This trial is registered with NCT03046745.


Sign in / Sign up

Export Citation Format

Share Document